Board Meeting10 Aug 2026, 05:40 pm
Concord Drugs Ltd Board Approves Un-audited Financial Results
AI Summary
Concord Drugs Ltd announced that its Board of Directors has approved the un-audited standalone and consolidated financial results for the quarter ended June 30, 2026. The board meeting took place on August 10, 2026. The company also noted the Limited Review Report from its statutory auditors. The financial results are available on the company's website and will be published in newspapers as per SEBI regulations. The meeting commenced at 4:00 PM and concluded at 5:00 PM.
Key Highlights
- Board approved standalone and consolidated un-audited financial results.
- Results are for the quarter ended June 30, 2026.
- Limited Review Report from auditors was noted.
- Results will be available on company and BSE websites.
- Financial results to be published in newspapers.
Price Impact
More from CONCORD